<DOC>
	<DOCNO>NCT01721915</DOCNO>
	<brief_summary>Background : Polycystic ovary syndrome ( PCOS ) common 5-10 % woman Austria . PCOS woman frequently present metabolic disturbance , hyperandrogenism infertility . New therapy concept warrant . In recent pilot study , vitamin D ( vitD ) supplementation significantly improve glucose metabolism fertility . However , efficacy vitD administration show individual variability indicate endogenous influence pharmacological effect . A recent genome-wide association study report three locus ( DHCR7 , CYP2R1 , GC ) associate vitD insufficiency . Moreover , vitD receptor ( VDR ) gene variant already know associate insulin resistance . Aim : To test hypothesis vitD efficient change metabolic parameter PCOS non-PCOS woman longitudinally generate data pharmacogenetic effect vitD relate genetic determinant adjust environmental factor . Primary outcome : Change baseline AUCgluc vitD treatment . Secondary outcome : To generate hypothesis change metabolic endocrine parameter follow vitD treatment associate vitD relate gene variant . Methods : 150 PCOS woman 25-hydroxyvitamin D ( cholecalciferol , [ 25 ( OH ) D ] ) level &lt; 30 ng/ml treat vitD ( 20,000 IU/wk ) placebo 2:1 randomize control trial 24 week investigate metabolic endocrine parameter well vitD relate genetic variant . In addition , 150 non-PCOS woman 25 ( OH ) D &lt; 30 ng/ml treat vitD ( 20,000 IU/wk ) placebo 2:1 randomize control trial 24 week investigate metabolic endocrine parameter well vitD relate genetic variant . The response vitD supplementation group analyse accord genotype profile . Significance : VitD might new therapeutic option without major side effect PCOS patient . Exploring specific loci pharmacogenetic vitD action would open new window therapy modulation PCOS metabolic disease .</brief_summary>
	<brief_title>Vitamin D Treatment , Pharmacogenetics Glucose Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>PCOS woman : 25 ( OH ) D level 30 ng/ml ( measure baseline visit ) Polycystic ovary syndrome define Androgen Excess Society ( AES ) criterion Female , age ≥ 18 &lt; 45 year BMI status : 75 PCOS woman BMI ≤25 kg/m² 75 PCOS woman BMI &gt; 25 kg/m² Written inform consent study entry Control woman : 25 ( OH ) D level 30 ng/ml ( measure baseline visit ) Female , age ≥ 18 &lt; 45 year BMI status : 75 nonPCOS woman BMI ≤25 kg/m² 75 nonPCOS woman BMI &gt; 25 kg/m² Written inform consent study entry PCOS woman : Hypercalcemia define serum calcium &gt; 2,7 mmol/L Pregnancy lactate woman Disorders associate androgen excess and/or menstrual irregularity apart PCOS ( thyroid dysfunction , hyperprolactinemia , adrenal hyperplasia , androgen secrete tumor ) Prevalent type 2 diabetes Regular intake vitD supplement time study entry Intake medication influence metabolic endocrine parameter ( insulin sensitizer , oral contraceptive , … ) last 3 month study entry Control woman : Hypercalcemia define serum calcium &gt; 2,7 mmol/L Established PCOS AES criterion 29 ( hyperandrogenism ( clinical and/or biochemical ) , oligo anovulation , polycystic ovary ultrasound ) Disorders associate androgen excess and/or menstrual irregularity apart PCOS ( thyroid dysfunction , hyperprolactinemia , adrenal hyperplasia , androgen secrete tumor ) Prevalent type 2 diabetes Pregnancy lactate woman Regular intake vitD supplement time study entry Intake medication influence metabolic endocrine parameter ( insulin sensitizer , oral contraceptive , … ) last 3 month study entry</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Polycystic Ovary Syndrome ( PCOS )</keyword>
	<keyword>glucose metabolism</keyword>
	<keyword>Vitamin D deficiency</keyword>
	<keyword>vitamin D supplementation</keyword>
	<keyword>pharmakogenetics</keyword>
	<keyword>woman</keyword>
</DOC>